P41 Assessment of cognitive function in a randomized, placebo-controlled, interventional trial conducted in patients with moderate-to-severe systemic lupus erythematosus (SLE)

Abstract

ObjectiveCognitive dysfunction is a characteristic yet heterogeneous feature of systemic lupus erythematosus (SLE) that can impact quality of life. In a phase 2 trial (NCT03656562) comprising two separate, placebo-controlled cohorts...